Neal JW - Search Results

1

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.

Marcoux N, Gettinger SN, O'Kane G, Arbour KC, Neal JW, Husain H, Evans TL, Brahmer JR, Muzikansky A, Bonomi PD, Del Prete S, Wurtz A, Farago AF, Dias-Santagata D, Mino-Kenudson M, Reckamp KL, Yu HA, Wakelee HA, Shepherd FA, Piotrowska Z, Sequist LV. Marcoux N, et al. Among authors: neal jw. J Clin Oncol. 2019 Feb 1;37(4):278-285. doi: 10.1200/JCO.18.01585. Epub 2018 Dec 14. J Clin Oncol. 2019. PMID: 30550363 Free PMC article.

2

Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations.

Neal JW, Sequist LV. Neal JW, et al. Nat Rev Clin Oncol. 2010 Feb;7(2):71-2. doi: 10.1038/nrclinonc.2009.191. Nat Rev Clin Oncol. 2010. PMID: 20118973 No abstract available.

3

First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutations.

Neal JW, Sequist LV. Neal JW, et al. Clin Adv Hematol Oncol. 2010 Feb;8(2):119-26. Clin Adv Hematol Oncol. 2010. PMID: 20386533 Review.

4

Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and Hh.

Neal JW, Sequist LV. Neal JW, et al. Curr Treat Options Oncol. 2010 Jun;11(1-2):36-44. doi: 10.1007/s11864-010-0120-6. Curr Treat Options Oncol. 2010. PMID: 20676809 Review.

5

AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancer.

Neal J, Wakelee H. Neal J, et al. Curr Opin Mol Ther. 2010 Aug;12(4):487-95. Curr Opin Mol Ther. 2010. PMID: 20677100

6

Cetuximab monotherapy in patients with advanced non-small cell lung cancer after prior epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Neal JW, Heist RS, Fidias P, Temel JS, Huberman M, Marcoux JP, Muzikansky A, Lynch TJ, Sequist LV. Neal JW, et al. J Thorac Oncol. 2010 Nov;5(11):1855-8. doi: 10.1097/JTO.0b013e3181f0bee0. J Thorac Oncol. 2010. PMID: 20975380 Free article. Clinical Trial.

7

One allele's loss is another's gain: alterations of NKX2-8 in non-small cell lung cancer.

Neal JW, Shaw AT. Neal JW, et al. Clin Cancer Res. 2011 Feb 15;17(4):638-9. doi: 10.1158/1078-0432.CCR-10-3081. Epub 2010 Dec 16. Clin Cancer Res. 2011. PMID: 21163872 Free PMC article.

8

Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.

Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV. Mak RH, et al. Among authors: neal jw. Oncologist. 2011;16(6):886-95. doi: 10.1634/theoncologist.2011-0040. Epub 2011 May 31. Oncologist. 2011. PMID: 21632451 Free PMC article.

9

Current management of small cell lung cancer.

Neal JW, Gubens MA, Wakelee HA. Neal JW, et al. Clin Chest Med. 2011 Dec;32(4):853-63. doi: 10.1016/j.ccm.2011.07.002. Epub 2011 Sep 28. Clin Chest Med. 2011. PMID: 22054891 Review.

10

Complex role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.

Neal JW, Sequist LV. Neal JW, et al. J Clin Oncol. 2012 Jun 20;30(18):2280-2. doi: 10.1200/JCO.2011.41.0860. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508823 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters